Participation of the hypothalamus-hypophysis axis in the sympathetic activation of human obesity

Guido Grassi, Gino Seravalle, Raffaella Dell'Oro, Carlo Turri, Lucia Pasqualinotto, Manuela Colombo, Giuseppe Mancia

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Previous studies have shown that hypothalamic and hypophyseal factors are involved in the acute sympathoexcitation induced by a variety of laboratory stimuli. Whether a chronic condition of sympathetic activation, such as that characterizing human obesity, is also dependent on these factors has never been investigated. In 40 normotensive obese subjects ([mean±SEM] age, 39.1±0.8 years) we measured blood pressure (Finapres), heart rate (ECG), and postganglionic muscle sympathetic nerve activity (MSNA) (microneurography). In 20 subjects measurements were repeated, according to a double-blind randomized sequence, after a midnight oral dose of dexamethasone (1 mg) (n=10) or placebo (n=10), while in the remaining subjects they were performed again after 1 week of a daily evening oral administration of 1 mg of dexamethasone (n=10) or placebo (n=10). The same protocol was performed in 16 age-matched lean normotensives. In both groups acute dexamethasone administration markedly reduced plasma cortisol (radioimmunoassay), without affecting hemodynamic and neural variables. In contrast to the acute administration, in obese subjects prolonged dexamethasone administration, although not affecting blood pressure and heart rate, significantly reduced both plasma cortisol (from 16.0±1.3 to 0.7±0.1 μg/dL; P

Original languageEnglish
Pages (from-to)1316-1320
Number of pages5
JournalHypertension
Volume38
Issue number6
Publication statusPublished - 2001

Fingerprint

Pituitary Gland
Dexamethasone
Hypothalamus
Obesity
Hydrocortisone
Heart Rate
Placebos
Blood Pressure
Radioimmunoassay
Oral Administration
Electrocardiography
Hemodynamics
Muscles

Keywords

  • Hormones
  • Hypothalamus
  • Obesity
  • Sympathetic nervous system

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Grassi, G., Seravalle, G., Dell'Oro, R., Turri, C., Pasqualinotto, L., Colombo, M., & Mancia, G. (2001). Participation of the hypothalamus-hypophysis axis in the sympathetic activation of human obesity. Hypertension, 38(6), 1316-1320.

Participation of the hypothalamus-hypophysis axis in the sympathetic activation of human obesity. / Grassi, Guido; Seravalle, Gino; Dell'Oro, Raffaella; Turri, Carlo; Pasqualinotto, Lucia; Colombo, Manuela; Mancia, Giuseppe.

In: Hypertension, Vol. 38, No. 6, 2001, p. 1316-1320.

Research output: Contribution to journalArticle

Grassi, G, Seravalle, G, Dell'Oro, R, Turri, C, Pasqualinotto, L, Colombo, M & Mancia, G 2001, 'Participation of the hypothalamus-hypophysis axis in the sympathetic activation of human obesity', Hypertension, vol. 38, no. 6, pp. 1316-1320.
Grassi, Guido ; Seravalle, Gino ; Dell'Oro, Raffaella ; Turri, Carlo ; Pasqualinotto, Lucia ; Colombo, Manuela ; Mancia, Giuseppe. / Participation of the hypothalamus-hypophysis axis in the sympathetic activation of human obesity. In: Hypertension. 2001 ; Vol. 38, No. 6. pp. 1316-1320.
@article{93389eb1a41440b1a389c04bda09bccf,
title = "Participation of the hypothalamus-hypophysis axis in the sympathetic activation of human obesity",
abstract = "Previous studies have shown that hypothalamic and hypophyseal factors are involved in the acute sympathoexcitation induced by a variety of laboratory stimuli. Whether a chronic condition of sympathetic activation, such as that characterizing human obesity, is also dependent on these factors has never been investigated. In 40 normotensive obese subjects ([mean±SEM] age, 39.1±0.8 years) we measured blood pressure (Finapres), heart rate (ECG), and postganglionic muscle sympathetic nerve activity (MSNA) (microneurography). In 20 subjects measurements were repeated, according to a double-blind randomized sequence, after a midnight oral dose of dexamethasone (1 mg) (n=10) or placebo (n=10), while in the remaining subjects they were performed again after 1 week of a daily evening oral administration of 1 mg of dexamethasone (n=10) or placebo (n=10). The same protocol was performed in 16 age-matched lean normotensives. In both groups acute dexamethasone administration markedly reduced plasma cortisol (radioimmunoassay), without affecting hemodynamic and neural variables. In contrast to the acute administration, in obese subjects prolonged dexamethasone administration, although not affecting blood pressure and heart rate, significantly reduced both plasma cortisol (from 16.0±1.3 to 0.7±0.1 μg/dL; P",
keywords = "Hormones, Hypothalamus, Obesity, Sympathetic nervous system",
author = "Guido Grassi and Gino Seravalle and Raffaella Dell'Oro and Carlo Turri and Lucia Pasqualinotto and Manuela Colombo and Giuseppe Mancia",
year = "2001",
language = "English",
volume = "38",
pages = "1316--1320",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Participation of the hypothalamus-hypophysis axis in the sympathetic activation of human obesity

AU - Grassi, Guido

AU - Seravalle, Gino

AU - Dell'Oro, Raffaella

AU - Turri, Carlo

AU - Pasqualinotto, Lucia

AU - Colombo, Manuela

AU - Mancia, Giuseppe

PY - 2001

Y1 - 2001

N2 - Previous studies have shown that hypothalamic and hypophyseal factors are involved in the acute sympathoexcitation induced by a variety of laboratory stimuli. Whether a chronic condition of sympathetic activation, such as that characterizing human obesity, is also dependent on these factors has never been investigated. In 40 normotensive obese subjects ([mean±SEM] age, 39.1±0.8 years) we measured blood pressure (Finapres), heart rate (ECG), and postganglionic muscle sympathetic nerve activity (MSNA) (microneurography). In 20 subjects measurements were repeated, according to a double-blind randomized sequence, after a midnight oral dose of dexamethasone (1 mg) (n=10) or placebo (n=10), while in the remaining subjects they were performed again after 1 week of a daily evening oral administration of 1 mg of dexamethasone (n=10) or placebo (n=10). The same protocol was performed in 16 age-matched lean normotensives. In both groups acute dexamethasone administration markedly reduced plasma cortisol (radioimmunoassay), without affecting hemodynamic and neural variables. In contrast to the acute administration, in obese subjects prolonged dexamethasone administration, although not affecting blood pressure and heart rate, significantly reduced both plasma cortisol (from 16.0±1.3 to 0.7±0.1 μg/dL; P

AB - Previous studies have shown that hypothalamic and hypophyseal factors are involved in the acute sympathoexcitation induced by a variety of laboratory stimuli. Whether a chronic condition of sympathetic activation, such as that characterizing human obesity, is also dependent on these factors has never been investigated. In 40 normotensive obese subjects ([mean±SEM] age, 39.1±0.8 years) we measured blood pressure (Finapres), heart rate (ECG), and postganglionic muscle sympathetic nerve activity (MSNA) (microneurography). In 20 subjects measurements were repeated, according to a double-blind randomized sequence, after a midnight oral dose of dexamethasone (1 mg) (n=10) or placebo (n=10), while in the remaining subjects they were performed again after 1 week of a daily evening oral administration of 1 mg of dexamethasone (n=10) or placebo (n=10). The same protocol was performed in 16 age-matched lean normotensives. In both groups acute dexamethasone administration markedly reduced plasma cortisol (radioimmunoassay), without affecting hemodynamic and neural variables. In contrast to the acute administration, in obese subjects prolonged dexamethasone administration, although not affecting blood pressure and heart rate, significantly reduced both plasma cortisol (from 16.0±1.3 to 0.7±0.1 μg/dL; P

KW - Hormones

KW - Hypothalamus

KW - Obesity

KW - Sympathetic nervous system

UR - http://www.scopus.com/inward/record.url?scp=0035671708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035671708&partnerID=8YFLogxK

M3 - Article

VL - 38

SP - 1316

EP - 1320

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 6

ER -